Skip to main content
MTVA logo

MetaVia Inc.

MTVANASDAQHealthcareBiotechnology

$1.26Today:- (-)1Y −87.20%

As of Oct 16, 2026 close

Market cap
$8.13M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.97$14.85
Volume (live)
-
Avg. volume (3M)
81.94K

MetaVia (MTVA) Stock Price & Financial Analysis

MetaVia Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$1.26 - $1.43
52-Week High$14.85
52-Week Low$0.97
Open$1.38
Volume (last close)75.72K
Average Volume (3M)81.94K
Technical Indicators
50-Day MA$1.57
200-Day MA$2.10
1-Year Change−87.20%
Size & Valuation
Market Cap8.13M
Shares Outstanding5.93M
Price to Book (P/B)1.19
EV/EBITDA0.29
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare MTVA with other stocks

MetaVia at a Glance

As of the Oct 16, 2026 close, MetaVia (MTVA) has a market capitalization of $8.13M.

As of its latest reported balance sheet, it holds $12.63M in cash and securities against $177.00K of debt, a net cash position of $12.46M.

MetaVia does not currently pay a dividend.

The share price is down 87.2% over the past year. At $1.26 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.97 to $14.85, below its 200-day moving average of $2.10.

Frequently Asked Questions About MetaVia

What is the current stock price for MTVA?

As of the Oct 16, 2026 close, MTVA stock trades at $1.26. The 52-week range is $0.97–$14.85, with a day range of $1.26–$1.43.

What is the P/E ratio for MTVA?

The P/E ratio (Price-to-Earnings) for MTVA is shown in the Key Statistics section. This valuation metric helps compare MetaVia Inc. to industry peers.

Does MTVA pay dividends?

MetaVia does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for MTVA?

Analyst ratings and recommendations for MTVA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MTVA?

As of the Oct 16, 2026 close, MetaVia's market capitalization is $7.5M, classifying it as a micro-cap company. MetaVia operates in the Healthcare sector within the Biotechnology industry.